Biodegradable polymer − cisplatin(IV) conjugate as a pro-drug of cisplatin(II)

详细信息    查看全文

• 作者：Haihua Xiao^a ; ^b ; Ruogu Qi^a ; ^b ; Shi Liu^a ; ^b ; Xiuli Hu^a ; Taicheng Duan^a ; Yonghui Zheng^a ; Yubin Huang^a ; Xiabin Jing^a ; ^{xbjing@ciac.jl.cn"" rel=""nofollow}
• 关键词：Cisplatin ; Platinum anti-tumor drugs ; Polymer-drug conjugate ; Cancer therapy ; Drug delivery
• 刊名：Biomaterials
• 出版年：2011
• 出版时间：October 2011
• 年：2011
• 卷：32
• 期：30
• 页码：7732-7739
• 全文大小：863 K

文摘

A Pt(IV) complex was covalently conjugated to a new biodegradable amphiphilic tri-block copolymer, MPEG-b-PCL-b-PLL, which contains pendant amino groups, to form a polymeric pro-drug of cisplatin(II), MPEG-b-PCL-b-PLL/Pt(IV). The conjugate was assembled into nano-micelles. The Pt(IV) complex, the polymer carrier and the conjugate were characterized systematically. In vitro release experiments showed that drug release from the polymer-Pt(IV) micelles follows an acid responsive and oxidation-reduction sensitive kinetics. HPLC-ICP-MS analysis revealed that cisplatin(II) can be released from the conjugate under an acidic plus a reductive condition which is available inside a cancerous cell. In vitro MTT assay demonstrated that the polymer-Pt(IV) micelles display higher cytotoxicity against SKOV-3 tumor cells than both cisplatin(II) and Pt(IV) complex. This enhanced cytotoxicity is attributed to effective internalization of the micelles by the cells via endocytosis mechanism, which was observed by fluorescence imaging and by direct determination of the platinum uptake by the cells. This polymer-Pt(IV) conjugate is a promising polymeric pro-drug of cisplatin in micellar form. It can protect the Pt(IV) complex against blood clearance. It can enter cancerous cells via endocytosis mechanism and then cisplatin(II) can be released. Therefore, this polymeric pro-drug of cisplatin is expected to find clinical applications in the future.